Report Code : CVMI120520253 | Published Date : May 12, 2025
The global animal stem cell banking market is projected to grow from USD 920 million in 2026 to USD 2.8 billion by 2031, at a 22.3% CAGR, driven by pet humanization and preventive healthcare trends.
Market Segmentation
By Cell Type
- Mesenchymal Stem Cells (MSCs) (65% share):
-
- Adipose-derived MSCs dominate regenerative applications
- Dental pulp MSCs show 30% higher differentiation potential
-
- Induced Pluripotent Stem Cells (iPSCs) (Fastest-growing at 28% CAGR):
-
- Reprogrammed from blood samples for genetic disease modeling
-
- Umbilical Cord Blood (XX%):
-
- 95% viability after 15 years cryopreservation
-
By Animal Type
- Companion Animals (XX% revenue):
-
- Dogs (XX%), cats (XX%), horses (15%)
-
- Livestock (Emerging):
-
- Elite breeding stock preservation
-
By Service
- Collection & Storage (XX%)
- Therapeutic Use (XX%)
2. Key Growth Drivers
1. Veterinary Medicine Advancements
- Osteoarthritis Treatment:
- Banked MSCs reduce TPLO surgery needs by 40%
- Chronic Kidney Disease:
- Feline iPSCs show tubular regeneration potential
2. Insurance & Financing Models
- Pet Health Savings Accounts:
- Nationwide offers 10% discount for enrolled animals
- Breeder Contracts:
- Champion bloodline preservation clauses
3. Technological Innovations
- Automated Processing:
- Gallant's CellArk reduces contamination risk to 0.01%
- CRISPR-Compatibility:
- Editas partners with VetStem for gene-edited therapies
3. Competitive Landscape
Company |
Breakthrough |
Market Impact |
VetStem |
Cryo-Cell partnership |
250K+ samples banked |
Gallant |
iPSC banking platform |
$120M valuation |
Animark |
Livestock breeding banks |
30% market share |
4. Future Outlook (2026-2031)
- 2027: First cloned pets from banked stem cells
- 2029: 3D bioprinting using banked cells
- 2031: 25% of purebred puppies banked at birth
Reasons To Buy

Scope

- VetStem Biopharma (USA)
- MediVet Biologics (USA)
- Aratana Therapeutics (USA)
- Boehringer Ingelheim (Germany)
- Magellan Stem Cells (Australia)
- VetCell Therapeutics (USA)
- Gallant (USA)
Animal Stem Cell Banking Market Report
- 1. Animal Stem Cell Banking Market Research Report
- 1.1 Study Objectives
- 1.2 Animal Stem Cell Banking Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2. Animal Stem Cell Banking Market Research Report - Preface
- 2.1 Animal Stem Cell Banking Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Cell Type
- 2.1.2 By Animal Type
- 2.1.3 By Service
- 2.1.4 By Region
- 2.1 Animal Stem Cell Banking Market Research Report – Detailed Scope and Definitions
- 3. Animal Stem Cell Banking Market Dynamics
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Cell Type, By Animal Type, By Service, By Country
- 3.3. Opportunities – By Cell Type, By Animal Type, By Service, By Country
- 3.4. Trends – By Cell Type, By Animal Type, By Service, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Animal Stem Cell Banking Market Research Report – DROTs Impact Analysis
-
- 4. Animal Stem Cell Banking Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5. Animal Stem Cell Banking Market, By Cell Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
- 5.1 Mesenchymal Stem Cells (MSCs)
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 Induced Pluripotent Stem Cells
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.3 Umbilical Cord Blood
- 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 Companion Animals
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 Livestock
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 Collection & Storage
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2 Therapeutic Use
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8. Animal Stem Cell Banking Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
- 8.1 North America
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.1 North America
- 9. North America Animal Stem Cell Banking Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
- 9.1 By Cell Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 9.1.1 Mesenchymal Stem Cells (MSCs)
- 9.1.2 Induced Pluripotent Stem Cells
- 9.1.3 Umbilical Cord Blood
- 9.2.1 Companion Animals
- 9.2.2 Livestock
- 9.3.1 Collection & Storage
- 9.3.2 Therapeutic Use
- 9.4.1 United States
- 9.4.2 Canada
- 9.5 North America Animal Stem Cell Banking Market – Opportunity Analysis Index, By Cell Type, By Animal Type, By Service, and Country, 2024 - 2031
- 9.6 Regional Trends Analysis
- 9.7 North America Animal Stem Cell Banking Market Research Report - Company Profiles
- 9.7.1 Company 1 (United States)
- 9.7.2 Company 2 (Canada)
- 9.7.3 Company 3 (Canada)
- 10.1 By Cell Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 10.1.1 Mesenchymal Stem Cells (MSCs)
- 10.1.2 Induced Pluripotent Stem Cells
- 10.1.3 Umbilical Cord Blood
- 10.2.1 Companion Animals
- 10.2.2 Livestock
- 10.3.1 Collection & Storage
- 10.3.2 Therapeutic Use
- 10.4.1 Germany
- 10.4.2 United Kingdom
- 10.4.3 France
- 10.4.4 Spain
- 10.4.5 Italy
- 10.4.6 Russia
- 10.4.7 Netherlands and Rest of Europe
- 10.5 Europe Animal Stem Cell Banking Market – Opportunity Analysis Index, By Cell Type, By Animal Type, By Service, and Country, 2024 - 2031
- 10.6 Regional Trends Analysis
- 10.7 Europe Animal Stem Cell Banking Market Research Report - Company Profiles
- 10.7.1 Company 1 (Germany)
- 10.7.2 Company 2 (United Kingdom)
- 10.7.3 Company 3 (United Kingdom)
- 11.1 By Cell Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 11.1.1 Mesenchymal Stem Cells (MSCs)
- 11.1.2 Induced Pluripotent Stem Cells
- 11.1.3 Umbilical Cord Blood
- 11.2.1 Companion Animals
- 11.2.2 Livestock
- 11.3.1 Collection & Storage
- 11.3.2 Therapeutic Use
- 11.4.1 China
- 11.4.2 Japan
- 11.4.3 India
- 11.4.4 South Korea
- 11.4.5 Australia & New Zealand
- 11.4.6 ASEAN
- 11.4.7 Rest of Asia-Pacific
- 11.5 Asia-Pacific Animal Stem Cell Banking Market – Opportunity Analysis Index, By Cell Type, By Animal Type, By Service, and Country, 2024 - 2031
- 11.6 Regional Trends Analysis
- 11.7 Asia-Pacific Animal Stem Cell Banking Market Research Report - Company Profiles
- 11.7.1 Company 1 (China)
- 11.7.2 Company 2 (Japan)
- 11.7.3 Company 3 (Japan)
- 12.1 By Cell Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 12.1.1 Mesenchymal Stem Cells (MSCs)
- 12.1.2 Induced Pluripotent Stem Cells
- 12.1.3 Umbilical Cord Blood
- 12.2.1 Companion Animals
- 12.2.2 Livestock
- 12.3.1 Collection & Storage
- 12.3.2 Therapeutic Use
- 12.4.1 Brazil
- 12.4.2 Mexico
- 12.4.3 Argentina
- 12.4.4 Peru
- 12.4.5 Colombia
- 12.4.6 Rest of Latin America
- 12.5 Latin America Animal Stem Cell Banking Market – Opportunity Analysis Index, By Cell Type, By Animal Type, By Service, and Country, 2024 - 2031
- 12.6 Regional Trends Analysis
- 12.7 Latin America Animal Stem Cell Banking Market Research Report - Company Profiles
- 12.7.1 Company 1 (Brazil)
- 12.7.2 Company 2 (Mexico)
- 12.7.3 Company 3 (Mexico)
- 13.1 By Cell Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 13.1.1 Mesenchymal Stem Cells (MSCs)
- 13.1.2 Induced Pluripotent Stem Cells
- 13.1.3 Umbilical Cord Blood
- 13.2.1 Companion Animals
- 13.2.2 Livestock
- 13.3.1 Collection & Storage
- 13.3.2 Therapeutic Use
- 13.4.1 Saudi Arabia
- 13.4.2 UAE
- 13.4.3 South Africa
- 13.4.4 Egypt
- 13.4.5 Israel
- 13.4.6 Rest of Middle East and Africa
- 13.5 Middle East and Africa Animal Stem Cell Banking Market – Opportunity Analysis Index, By Cell Type, By Animal Type, By Service, and Country, 2024 - 2031
- 13.6 Regional Trends Analysis
- 13.7 Middle East and Africa Animal Stem Cell Banking Market Research Report - Company Profiles
- 13.7.1 Company 1 (Saudi Arabia)
- 13.7.2 Company 2 (UAE)
- 13.7.3 Company 3 (UAE)
- 14.1 Strategic Dashboard of Top Market Players
- 14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
- 14.2.1 VetStem Biopharma (USA)
- 14.2.2 MediVet Biologics (USA)
- 14.2.3 Aratana Therapeutics (USA)
- 14.2.4 Boehringer Ingelheim (Germany)
- 14.2.5 Magellan Stem Cells (Australia)
- 14.2.6 VetCell Therapeutics (USA)
- 14.2.7 Gallant (USA)
- 9.1 By Cell Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 15. Data Collection Method and Research Approach
- 16. Principal Presumptions and Acronyms